Enzo Biochem, Inc. v. Applera Corp., 599 F.3d 1325 (Fed. Cir. 2010) (LINN, Michel & Plager), rehearing and rehearing en banc denied, 605 F.3d 1347 (Fed. Cir. 2010) (PLAGER, dissenting from denial of panel rehearing) EnzoBiochem03242010
MAJOR ISSUES: definiteness of claim language; biotechnology; nucelic acid labeling and detection; “substantially interfere”; summary judgment on invalidity by anticipation; prior art references; claim interpretation; claim differentiation Read CPLRG 0037